BUY Strides Pharma Science Limited — Sachin Gupta
bySachin GuptaHorizon: 1–3 months6 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor issued a 1-year BUY call in the last 30 days
Advisor consensus · adjacent horizon·2 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Strides Pharma Science
- BUY — Rakesh Bansal21 Sept 2026 · ~2 weeks · target ₹1,278 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities8 Sept 2026 · ~2 weeks · target ₹1,250 · SL hit
- BUY — Nilesh Jain, Centrum Broking7 Sept 2026 · ~3 months · target ₹1,200 · Target hit
- BUY — Geojit Financial Services2 Jul 2026 · ~1 year · target ₹1,352 · Active
- BUY — Rajesh Satpute29 Jun 2026 · ~2 weeks · target ₹1,150 · SL hit
More from Sachin Gupta
- SELL Prestige Estates Projects23 Oct 2026 · ~2 weeks · target ₹1,350 · Active
- SELL Manappuram Finance23 Oct 2026 · ~2 weeks · target ₹275 · Active
- BUY Punjab National Bank21 Oct 2026 · ~2 weeks · target ₹132 · Active
- BUY MphasiS21 Oct 2026 · ~2 weeks · target ₹2,700 · SL hit
- BUY NTPC19 Oct 2026 · ~3 months · target ₹340 · Active

